Authors:
Kakolyris, S
Giatromanolaki, A
Koukourakis, M
Powis, G
Souglakos, J
Sivridis, E
Georgoulias, V
Gatter, KC
Harris, AL
Citation: S. Kakolyris et al., Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer, CLIN CANC R, 7(10), 2001, pp. 3087-3091
Authors:
Papakostas, P
Kouroussis, C
Androulakis, N
Samelis, G
Aravantinos, G
Kalbakis, K
Sarra, E
Souglakos, J
Kakolyris, S
Georgoulias, V
Citation: P. Papakostas et al., First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study, EUR J CANC, 37(15), 2001, pp. 1833-1838
Authors:
Kakolyris, S
Mavroudis, D
Tsavaris, N
Souglakos, J
Tsiafaki, P
Kalbakis, K
Agelaki, S
Androulakis, N
Georgoulias, V
Citation: S. Kakolyris et al., Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study, ANN ONCOL, 12(2), 2001, pp. 193-197
Authors:
Kouroussis, C
Kakolyris, S
Mavroudis, D
Androulakis, N
Kalbakis, K
Agelaki, S
Sarra, E
Souglakos, J
Christodoulakis, M
Samonis, G
Georgoulias, V
Citation: C. Kouroussis et al., A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors, AM J CL ONC, 24(4), 2001, pp. 404-407
Authors:
Samonis, G
Anatoliotaki, M
Apostolakou, H
Souglakos, J
Georgoulias, V
Citation: G. Samonis et al., Fatal septicemia and meningitis due to Morganella morganii in a patient with Hodgkin's disease, SC J IN DIS, 33(7), 2001, pp. 553-555
Authors:
Kakolyris, S
Kouroussis, C
Souglakos, J
Mavroudis, D
Agelaki, S
Kalbakis, K
Androulakis, N
Vardakis, N
Vamvakas, L
Georgoulias, V
Citation: S. Kakolyris et al., A phase I clinical trial of topotecan given every 2 weeks in patients withrefractory solid tumors, ONCOL-BASEL, 61(4), 2001, pp. 265-270
Authors:
Kouroussis, C
Souglakos, J
Kakolyris, S
Mavroudis, D
Malamos, N
Kalbakis, K
Androulakis, N
Agelaki, A
Vardakis, N
Samonis, G
Georgoulias, V
Citation: C. Kouroussis et al., Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: A phase II study, ONCOL-BASEL, 61(1), 2001, pp. 36-41
Authors:
Kakolyris, S
Souglakos, J
Kouroussis, C
Androulakis, N
Mavroudis, D
Kalbakis, K
Kotsakis, A
Vardakis, N
Koukourakis, M
Romanos, J
Georgoulias, V
Citation: S. Kakolyris et al., A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer, ONCOL-BASEL, 60(3), 2001, pp. 207-213
Authors:
Kalbakis, K
Kouroussis, C
Kakolyris, S
Mavroudis, D
Souglakos, J
Agelaki, S
Vamvakas, L
Christodoulakis, M
Stylianou, K
Georgoulias, V
Citation: K. Kalbakis et al., Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuousinfusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes, BR J CANC, 85(6), 2001, pp. 798-802
Authors:
Kakolyris, S
Kouroussis, C
Kalbakis, K
Mavroudis, D
Souglakos, J
Vardakis, N
Kremos, S
Georgoulias, V
Citation: S. Kakolyris et al., Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin, ANN ONCOL, 11(6), 2000, pp. 757-760
Authors:
Kouroussis, C
Agelaki, S
Mavroudis, D
Souglakos, J
Kakolyris, S
Kalbakis, K
Vardakis, N
Reppa, D
Hatzidaki, D
Samonis, G
Georgoulias, V
Citation: C. Kouroussis et al., A dose escalation study of weekly docetaxel in patients with advanced solid tumors, CANC CHEMOT, 46(6), 2000, pp. 488-492
Authors:
Mavroudis, D
Kourousis, C
Androulakis, N
Kalbakis, K
Agelaki, S
Kakolyris, S
Souglakos, J
Sarra, E
Vardakis, N
Hatzidaki, D
Sarmonis, G
Georgoulias, V
Citation: D. Mavroudis et al., Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) - A phase II trial, AM J CL ONC, 23(4), 2000, pp. 341-344
Authors:
Kouroussis, C
Samonis, G
Androulakis, N
Souglakos, J
Voloudaki, A
Dimopoulos, MA
Kotsakis, T
Kakolyris, S
Kalbakis, K
Georgoulias, V
Citation: C. Kouroussis et al., Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy - A report of five cases, AM J CL ONC, 23(3), 2000, pp. 309-313
Authors:
Kakolyris, S
Souglakos, J
Agelaki, S
Kourousis, C
Mavroudis, D
Sarra, E
Malliotakis, P
Georgoulias, V
Citation: S. Kakolyris et al., A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy, LUNG CANC, 30(3), 2000, pp. 193-198
Authors:
Mavroudis, D
Kourousis, C
Kakolyris, S
Agelaki, S
Kalbakis, K
Androulakis, N
Souglakos, J
Vardakis, N
Samonis, G
Georgoulias, V
Citation: D. Mavroudis et al., Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report, SEMIN ONCOL, 27(1), 2000, pp. 25-30
Authors:
Kotsakis, A
Sarra, E
Peraki, M
Koukourakis, M
Apostolaki, S
Souglakos, J
Mavromanomakis, E
Vlachonikolis, J
Georgoulias, V
Citation: A. Kotsakis et al., Docetaxel-induced lymphopenia in patients with solid tumors - A prospective phenotypic analysis, CANCER, 89(6), 2000, pp. 1380-1386
Authors:
Kouroussis, C
Androulakis, N
Kakolyris, S
Souglakos, J
Kotsakis, T
Mavroudis, D
Katsogridakis, K
Vardakis, N
Hatzidaki, D
Samonis, G
Vlachonikolis, J
Georgoulias, V
Citation: C. Kouroussis et al., Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer, J CL ONCOL, 17(3), 1999, pp. 862-869